ACOG diverges from CDC vaccine guidance
Analysis based on 7 articles · First reported Jun 10, 2026 · Last updated Jun 11, 2026
The divergence in vaccine recommendations creates uncertainty for healthcare providers and patients, potentially affecting vaccine uptake and public health outcomes. For pharmaceutical companies like Pfizer, whose products are part of the recommended schedules, the shifting guidelines could influence demand and market stability.
The American College of Obstetricians and Gynecologists (ACOG) has released a maternal vaccine schedule that for the first time diverges from the United States — Centers for Disease Control and Prevention (CDC) guidance. ACOG recommends four vaccines during pregnancy: flu, COVID-19, Tdap, and RSV, with additional recommendations for specific populations. This move comes after the CDC, under Health Secretary Robert F. Kennedy Jr., overhauled its maternal vaccine schedule, removing routine COVID-19 and seasonal influenza vaccinations for healthy pregnant individuals. The American Academy of Pediatrics and other medical societies have endorsed ACOG's schedule, citing confusion from changing national recommendations and vaccine misinformation. A federal judge has blocked parts of the United States — United States Department of Health and Human Services' reshaping of federal vaccine policy, though the Trump administration has vowed to appeal.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard